Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Eldad Melamed »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Elan D. Louis < Eldad Melamed < Elena Caputo  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000231 (2009) Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]Validation of the freezing of gait questionnaire in patients with Parkinson's disease
000308 (2008) C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France]A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
000432 (2004) C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]Levodopa in the treatment of Parkinson's disease: Current controversies
000512 (2001) Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Humans
4Parkinson disease
3Nervous system diseases
3Parkinson Disease (drug therapy)
3Parkinson's disease
3Treatment
2Aged
2Antiparkinson Agents (adverse effects)
2Antiparkinson Agents (therapeutic use)
2Corpus Striatum (drug effects)
2Double-Blind Method
2Female
2Human
2Indans (therapeutic use)
2Levodopa
2Levodopa (adverse effects)
2Male
2Middle Aged
2Neuroprotective Agents (therapeutic use)
2Rasagiline
2levodopa
2rasagiline
1Adult
1Aged, 80 and over
1Agonist
1Analysis of Variance
1Antiparkinson Agents (pharmacokinetics)
1Antiparkinson agent
1Apomorphine (administration & dosage)
1Apomorphine (diagnostic use)
1Apomorphine (pharmacology)
1Catechols (therapeutic use)
1Chemotherapy
1Consensus conference
1Corpus Striatum (metabolism)
1Decision Making
1Diagnosis
1Domperidone (administration & dosage)
1Domperidone (diagnostic use)
1Domperidone (pharmacology)
1Dopamine Agonists (administration & dosage)
1Dopamine Agonists (diagnostic use)
1Dopamine Agonists (pharmacology)
1Dopamine Antagonists (administration & dosage)
1Dopamine Antagonists (diagnostic use)
1Dopamine Antagonists (pharmacology)
1Dopamine agonist
1Dopamine receptor
1Dose-Response Relationship, Drug
1Drug Administration Schedule
1Dyskinesia, Drug-Induced (etiology)
1Freezing
1Freezing Reaction, Cataleptic (drug effects)
1Freezing Reaction, Cataleptic (physiology)
1Gait Disorders, Neurologic (chemically induced)
1Gait Disorders, Neurologic (diagnosis)
1Gait Disorders, Neurologic (drug therapy)
1Gait Disorders, Neurologic (physiopathology)
1Guidelines as Topic
1Levodopa (administration & dosage)
1Levodopa (diagnostic use)
1Levodopa (pharmacokinetics)
1Levodopa (pharmacology)
1Levodopa (therapeutic use)
1Modification
1Nitriles (therapeutic use)
1Parkinson Disease (diagnosis)
1Pharmacologic test
1Placebo
1Principal Component Analysis
1Psychiatric Status Rating Scales
1Questionnaire
1Questionnaires
1Receptors, Dopamine (drug effects)
1Receptors, Dopamine (metabolism)
1Recommendation
1Reproducibility of Results
1Retrospective Studies
1Severity of Illness Index
1Statistics as Topic
1Substantia Nigra (drug effects)
1Time Factors
1Treatment Outcome
1Validation
1apomorphine
1delayed start design
1diagnosis
1disease modification
1dyskinesia
1freezing of gait
1motor complications
1neuroprotection
1neurotoxicity
1treatment
1validation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Eldad Melamed" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Eldad Melamed" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Eldad Melamed
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024